Magenta Lifecare (BSE 544188)₹11.40+20.13%Furniture, Home Furnishing
In the Mar 2026 quarter (standalone), Magenta Lifecare reported sales of ₹8.98 Cr, up 107.4% from Mar 2025, and net profit of ₹0.12 Cr, up 200.0% year on year. For the year to Mar 2026, sales were ₹14.41 Cr and net profit ₹0.10 Cr.
Company filings, standalone accounts; latest reported quarter Mar 2026
| Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Sales | 4.54 | 4.06 | 4.70 | 5.85 | 4.33 | 5.45 | 8.98 |
| Expenses | 4.68 | 4.23 | 3.02 | 6.09 | 4.10 | 5.17 | 8.90 |
| Operating Profit | −0.13 | −0.18 | 1.67 | −0.26 | 0.22 | 0.25 | 0.06 |
| OPM % | −3.1% | −4.7% | 35.6% | −4.7% | 5.3% | 4.8% | 0.8% |
| Other Income | 0.45 | 0.28 | 0.00 | 0.53 | 0.04 | 0.06 | 0.72 |
| Interest | 0.34 | 0.32 | 0.22 | 0.10 | 0.16 | 0.16 | 0.20 |
| Depreciation | 0.21 | 0.00 | 0.21 | 0.11 | 0.11 | 0.11 | 0.42 |
| Profit before tax | −0.24 | −0.24 | 1.27 | 0.07 | 0.02 | 0.07 | 0.19 |
| Tax % | 30.4% | 0.0% | 27.8% | 50.0% | −400.0% | 33.3% | 22.2% |
| Net Profit | −0.29 | −0.22 | 0.90 | 0.03 | 0.04 | 0.04 | 0.12 |
| EPS (Rs) | −1.94 | −0.48 | 1.86 | 0.07 | 0.08 | 0.06 | 0.20 |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Sales | 9.63 | 9.22 | 9.05 | 8.73 | 10.17 | 14.41 |
| Expenses | 8.59 | 8.16 | 8.18 | 7.22 | 10.21 | 14.06 |
| Operating Profit | 1.03 | 1.05 | 0.86 | 1.50 | −0.04 | 0.32 |
| OPM % | 10.7% | 11.4% | 9.6% | 17.2% | −0.5% | 2.3% |
| Other Income | 0.00 | 0.13 | 0.48 | 0.27 | 0.58 | 0.74 |
| Interest | 0.67 | 0.76 | 0.83 | 0.55 | 0.26 | 0.37 |
| Depreciation | 0.21 | 0.21 | 0.21 | 0.21 | 0.21 | 0.52 |
| Profit before tax | 0.18 | 0.24 | 0.33 | 1.04 | 0.08 | 0.20 |
| Tax % | −11.7% | 17.4% | 21.9% | 28.1% | −14.3% | 42.1% |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Profit | 0.18 | 0.18 | 0.24 | 0.73 | 0.07 | 0.10 |
| EPS (Rs) | 1.57 | 1.35 | 1.61 | 1.51 | 0.13 | 0.17 |
| Dividend payout % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Equity Capital | 1.21 | 1.41 | 1.53 | 4.86 | 6.86 | 6.86 |
| Reserves | 0.20 | 2.19 | 3.66 | 1.96 | 7.04 | 6.31 |
| Borrowings | 9.85 | 7.58 | 4.54 | 3.27 | 2.01 | 5.30 |
| Other Liabilities | 3.35 | 2.97 | 2.78 | 2.97 | 2.22 | 5.63 |
| Total Liabilities | 14.61 | 14.15 | 12.51 | 13.06 | 18.13 | 24.10 |
| Fixed Assets | 2.20 | 2.02 | 1.84 | 1.68 | 1.89 | 1.40 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.84 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 12.41 | 12.13 | 10.67 | 11.38 | 16.24 | 20.86 |
| Inventories | 6.14 | 6.52 | 6.73 | 7.28 | 7.50 | 7.85 |
| Trade receivables | 3.37 | 2.63 | 1.42 | 2.08 | 4.49 | 8.51 |
| Cash & equivalents | 0.26 | 0.33 | 0.33 | 0.17 | 1.43 | 0.92 |
| Total Assets | 14.61 | 14.15 | 12.51 | 13.06 | 18.13 | 24.10 |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Cash from operating activity | 1.08 | 1.35 | 2.16 | −0.97 | −4.14 | 1.12 |
| Cash from investing activity | −0.31 | −0.01 | −0.31 | −0.04 | −0.39 | −2.79 |
| Cash from financing activity | −0.57 | −1.28 | −1.86 | 0.88 | 5.82 | 1.17 |
| Net cash flow | 0.22 | 0.08 | 0.00 | −0.17 | 1.27 | −0.52 |
| Capex | 0.33 | 0.03 | 0.03 | 0.05 | 0.41 | 1.86 |
| Free cash flow | 0.76 | 1.35 | 2.14 | −1.01 | −4.54 | −0.71 |
| CFO / OP % | 108.1% | 132.1% | 257.1% | −46.0% | 8,320.0% | 342.1% |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Debtor days | 127 | 104 | 57 | 86 | 160 | 215 |
| Inventory days | 315 | 364 | 411 | 497 | 333 | 251 |
| Days payable | 118 | 98 | 150 | 162 | 86 | 146 |
| Cash conversion cycle | 322 | 368 | 316 | 420 | 406 | 318 |
| Working capital days | 88 | 82 | 68 | 190 | 296 | 200 |
| ROCE % | — | 8.9% | 11.0% | 16.0% | 2.6% | 3.6% |
For the Mar 2026 quarter, Magenta Lifecare reported sales of ₹8.98 Cr, up 107.4% year on year and net profit of ₹0.12 Cr, up 200.0% year on year. The operating margin was 0.8%.
Magenta Lifecare's sales for the year to Mar 2026 were ₹14.41 Cr.
Net profit for the year to Mar 2026 was ₹0.10 Cr. Earnings per share over the same trailing period were ₹0.17.
Magenta Lifecare reported borrowings of ₹5.30 Cr at Mar 2026, against cash and equivalents of ₹0.92 Cr.
Cash from operations was ₹1.12 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹0.71 Cr.